TRH protection against memory retrieval deficits is independent of endocrine effects

An electrobrainshock (EBS)-induced memory retrieval deficit was produced in normal and hypophysectomized mice. In normal mice, thyrotropin-releasing hormone (TRH) (0.1 to 30 mg/kg) protected against this EBS disruption of memory after intraperitoneal but not oral (1.0 to 100 mg/kg) administration. I...

Full description

Saved in:
Bibliographic Details
Published inPharmacology, biochemistry and behavior Vol. 41; no. 1; pp. 145 - 152
Main Authors Stwertka, S.A., Vincent, G.P., Gamzu, E.R., MacNeil, D.A., Verderese, A.G.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 1992
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An electrobrainshock (EBS)-induced memory retrieval deficit was produced in normal and hypophysectomized mice. In normal mice, thyrotropin-releasing hormone (TRH) (0.1 to 30 mg/kg) protected against this EBS disruption of memory after intraperitoneal but not oral (1.0 to 100 mg/kg) administration. In hypophysectomized mice, TRH (0.3 and 3.0 mg/kg) also protected against the retrieval deficit induced by EBS. The memory protection afforded by TRH was unrelated to its ability to elevate plasma levels of triiodothyronine (T 3) and thyroxine (T 4), nor was TRH's memory protection mediated through an anticonvulsive mechanism. These results support the notion that TRH may play an important role in memory modulation and may have therapeutic value in certain disease states in humans.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0091-3057
1873-5177
DOI:10.1016/0091-3057(92)90074-P